bromocriptine has been researched along with desipramine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (36.36) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brooke, D; Fudala, PJ; Johnson, RE | 1 |
| Baca, L; Martinelli, L | 1 |
| Kleven, MS; Woolverton, WL | 1 |
| Dackis, CA; Gold, MS; Pottash, AL | 1 |
| Ensinger, H; Hedler, L; Majewski, H; Starke, K | 1 |
| Billett, W; Giannini, AJ | 1 |
| Berman, ML; Tennant, F | 1 |
| Jackson, DM; Jenkins, OF | 2 |
| Dackis, CA; Gold, MS | 1 |
| Jenner, P; Marsden, CD; Reavill, C | 1 |
| Asanuma, M; Kawai, M; Kohno, M; Masumizu, T; Mori, A; Ogawa, N; Tanaka, K | 1 |
| Johnson, DN; Vocci, FJ | 1 |
| Schottenfeld, RS | 1 |
| Gan, Q; Knuepfer, MM | 1 |
| Duggan, C; Ferriter, M; Huband, N; Khalifa, N; Lieb, K; Stoffers, J; Völlm, BA | 1 |
| Chassain, C; Durif, F; Hafidi, A; Ouachikh, O; Pagès, G | 1 |
| Cheung, NH; Gibbon, S; Khalifa, NR; McCarthy, L; Völlm, BA | 1 |
6 review(s) available for bromocriptine and desipramine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties.
Topics: Adenylyl Cyclases; alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Dextroamphetamine; Drug Interactions; Fluoxetine; Humans; Methyltyrosines; Mice; Motor Activity; Nialamide; Nomifensine; Nucleus Accumbens; Rats; Receptors, Dopamine; Reserpine; Stereotyped Behavior | 1985 |
Pharmacological approaches to cocaine addiction.
Topics: Brain Chemistry; Bromocriptine; Cocaine; Desipramine; Dopamine; Euphoria; Humans; Receptors, Dopamine; Reward; Substance Withdrawal Syndrome; Substance-Related Disorders; Tyrosine | 1985 |
Medications development at the National Institute on Drug Abuse: focus on cocaine.
Topics: Bromocriptine; Cocaine; Desipramine; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Pharmacological interventions for antisocial personality disorder.
Topics: Adult; Aggression; Alcohol-Related Disorders; Amantadine; Antisocial Personality Disorder; Anxiety; Bromocriptine; Desipramine; Female; Humans; Male; Nortriptyline; Phenytoin; Psychotropic Drugs; Randomized Controlled Trials as Topic | 2010 |
Pharmacological interventions for antisocial personality disorder.
Topics: Adult; Aggression; Alcohol-Related Disorders; Amantadine; Antisocial Personality Disorder; Anxiety; Bromocriptine; Desipramine; Female; Humans; Male; Middle Aged; Nortriptyline; Phenytoin; Placebos; Psychotropic Drugs; Randomized Controlled Trials as Topic | 2020 |
2 trial(s) available for bromocriptine and desipramine
| Article | Year |
|---|---|
Weighing up the pros and cons: help-seeking by drug misusers in Baltimore, USA.
Topics: Adult; Bromocriptine; Buprenorphine; Cocaine; Desipramine; Fear; Female; Fluoxetine; Humans; Male; Methadone; Middle Aged; Motivation; Opioid-Related Disorders; Patient Acceptance of Health Care; Phencyclidine Abuse; Substance Abuse Treatment Centers; Substance-Related Disorders; Urban Population | 1992 |
Bromocriptine-desipramine protocol in treatment of cocaine addiction.
Topics: Adult; Bromocriptine; Clinical Trials as Topic; Cocaine; Desipramine; Drug Therapy, Combination; Humans; Male; Psychiatric Status Rating Scales; Random Allocation; Substance-Related Disorders; Time Factors | 1987 |
14 other study(ies) available for bromocriptine and desipramine
| Article | Year |
|---|---|
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant.
Topics: Bromocriptine; Dantrolene; Desipramine; Dopamine; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Norepinephrine | 1990 |
Effects of bromocriptine and desipramine on behavior maintained by cocaine or food presentation in rhesus monkeys.
Topics: Animals; Behavior, Animal; Bromocriptine; Cocaine; Conditioning, Operant; Desipramine; Female; Food; Macaca mulatta; Male; Reinforcement Schedule | 1990 |
Central stimulant abuse: neurochemistry and pharmacotherapy.
Topics: Antipsychotic Agents; Brain; Bromocriptine; Cocaine; Desipramine; Dopamine; Euphoria; Humans; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1986 |
Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
Topics: Anesthesia; Animals; Benzazepines; Blood Pressure; Bromocriptine; Clonidine; Decerebrate State; Desipramine; Domperidone; Dopamine; Female; Male; Neurons; Nitroprusside; Norepinephrine; Propranolol; Rabbits; Receptors, Dopamine; Receptors, Neurotransmitter | 1985 |
Stepwise detoxification from cocaine. A promising regimen.
Topics: Adolescent; Adult; Amantadine; Bromocriptine; Cocaine; Desipramine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan; Tyrosine | 1988 |
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Drug Synergism; Fluoxetine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Reserpine | 1985 |
Metabolite involvement in bromocriptine-induced circling behaviour in rodents.
Topics: Amphetamine; Animals; Apomorphine; Biotransformation; Bromocriptine; Desipramine; Female; Hydroxydopamines; Male; Medial Forebrain Bundle; Methyltyrosines; Mice; Motor Activity; Nomifensine; Paralysis; Proadifen; Rats; Receptors, Dopamine; Receptors, Neurotransmitter; Reserpine; Sleep; Zoxazolamine | 1980 |
Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro.
Topics: Animals; Bromocriptine; Carbidopa; Corpus Striatum; Desipramine; Dopamine; Free Radical Scavengers; Hydroxyl Radical; Injections, Intraventricular; Levodopa; Male; Mice; Mice, Inbred ICR; Oxidopamine | 1994 |
Clinical trials of pharmacologic treatments in pregnant women--methodologic considerations.
Topics: Bromocriptine; Buprenorphine; Clinical Trials as Topic; Desipramine; Dopamine Agonists; Female; Humans; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Research Design; Substance-Related Disorders | 1995 |
Effects of proposed treatments for cocaine addiction on hemodynamic responsiveness to cocaine in conscious rats.
Topics: Animals; Bromocriptine; Buprenorphine; Cocaine; Desipramine; Diazepam; Dizocilpine Maleate; Hemodynamics; Male; Piperazines; Rats; Rats, Sprague-Dawley; Substance-Related Disorders | 1997 |
mGlu5 receptor antagonist blocks bromocriptine-induced conditioned place preference in bilateral mesolimbic-lesioned rat.
Topics: Adrenergic Agents; Adrenergic Uptake Inhibitors; Animals; Antiparkinson Agents; Bromocriptine; Conditioning, Operant; Desipramine; Excitatory Amino Acid Antagonists; Exploratory Behavior; Gene Expression Regulation; Male; Maze Learning; Nucleus Accumbens; Oxidopamine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Reinforcement, Psychology; Thiazoles; Ventral Tegmental Area | 2017 |